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Introduction
Different cartilage types and functions
Cartilage is a connective tissue that serves as a structural support 
in several areas of the body. Its main function is maintaining the shape 
(ear, nose) and absorbing shocks (joints). Three different types of 
cartilage coexist in humans. Hyaline cartilage is the most abundant and 
is found mainly in joints and also in the trachea and nasal septum. With 
a blue aspect and a smooth surface, it is usually surrounded by a thin 
membrane called perichondrium. At biochemical level, the extracellular 
matrix contains type II collagen, aggrecan, keratan and chondroitin sulfate. 
Elastic cartilage is found in organs like ear, Eustachian tube, larynx, nostril 
opening and epiglottis. Its function is to allow both support and flexibility. 
These characteristics are provided by its high elastin and collagen content. 
The third type is called fibrocartilage is restricted to areas that need a 
high resistance to strength, like intervertebral discs, sacroiliac and 
costochondral joints, or pubis symphysis. In addition to type II collagen, 
fibrocartilage contains type I collagen as well.
Cartilage during development
Differences between cartilage composition and functions are 
explained by their distinct origin during embryologic development. 
Indeed, hyaline cartilage derives from the mesenchyme with key role of 
SOX transcription factors during its formation. Under the effect of paracrine 
factors and hormones, cartilage specific genes and mesenchymal stem 
cells are activated and differentiated toward chondrocytes (Decker, 
2017). The facial cartilage develops from neural crest (neuroectoderm) 
and mesenchyme. During development, cells migrate to specific locations 
where they differentiate under the control of HOX genes, leading to 
segmentary organization and different segments in buds of the face and 
pharyngeal arches (Suzuki and Osumi, 2015). The external ear derives 
from the first branchial cleft (Anthwal and Thompson, 2016). Tracheal 
cartilage in its turn, develops from endodermal origin. Beside SOX and 
HOX transcription factors, were described to play key roles in cartilage 
development. Knockdown experiments in X. laevis highlighted the role of 
FOXN3 in the development of new cartilage. RUNX3 and SOX9B are also 
involved through a regulation cascade via BMPs (Dalcq,et al., 2012). In 
addition, MiR 140 was also described to be involved in cranial cartilage 
formation via PDGFRa, since it provokes cranio facial defects in both zebra 
fish and mouse.
Cartilage lesions
Depending on its location, cartilage is subject to several injuries 
and lesions. In joints, osteoarthritis (OA) and rheumatoid arthritis (RA) 
are degenerative diseases with multiple causes, including mechanical 
stresses, genetic factors and trauma. Concerning head and neck cartilage, 
main lesions are from traumatic, congenital and metabolic origin. Beside, 
a lot of congenital abnormalities of the ear (microtia, anotia) and the 
nose (Apert syndrom) lead to heavy and multiple interventions with 
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many prostheses or autologous transplantations which could provoke 
donor sites. The trachea is also subject to trachea bronchial tumors and 
congenital deformity. Tracheal stenosis is also an especially risk after an 
intubation. Unfortunately, only few options exist in regards to ear and nose 
reconstruction, with stents application and tracheotomy. In addition, the 
growing number of cancers in the area of head and neck affects cartilage 
and therefore increases the need of its reconstruction in several areas.
Specificity of cartilage biology
Cartilage is avascular and non-innervated tissue. During decades, it 
was described to harbor a single cell type, namely chondrocytes. However, 
it also contains progenitors which activate and participate in its repair (OA 
cartilage). However due to its hypoxic microenvironment with a gradient of 
oxygen comprised between 1 to 7% of oxygen, the regeneration potential 
is very limited. At biochemical level, the cartilaginous extra cellular matrix 
(ECM) is specific to the tissue and contains a complex macromolecular 
network of collagens, proteoglycans and several glycoproteins, and possi-
bly elastin for some areas (ear). The cell-ECM interactions are established 
through integrins, CD44 and proteoglycans receptors (syndecans). The 
contents of ECM differs in both quality and quantity, depending on the 
function and type of cartilage.
Clinical approaches of cartilage reconstruction
Historically, OA is the main cartilage disease targeted by reconstruc-
tion at clinical level. Therefore, orthopedic surgeons used several techni-
ques with more or less success:  microfracture, mosaicplasty, autologous 
chondrocyte implantation and allograft. Auricular cartilage is also targeted 
by cartilage reconstruction. Its complex anatomic tridimensional structure 
is a challenge for reconstruction. Here again, multiple approaches were 
used between two- and four stage techniques using autologous costal 
cartilage which led to good results in terms of contour and framework 
definition. However, long term outcomes show several cons, including 
the the need to carry out several operations, calcification of the construct, 
necrosis, contraction of the skin, as well as cartilage resorption (Whatson 
and Hecht, 2017). Moreover, even if the two-step techniques provides 
the best pros regarding long term outcomes, limits in its use concern 
the age of patient concerned (under age of 10) (Jessop et al, 2016). All 
in all, despite these approaches, it is still yet very difficult to reproduce 
native tissue with appropriate flexibility, strength and elasticity. Due to 
its complex anatomy and function, trachea reconstruction undergoes 
several challenges. It needs to build a safe and stable conduct to ensure 
breathing without assistance and avoid airways collapses.  Therefore, 
multiple trials were done with insertion of small pieces of cartilage to 
strengthen the upper airways. The trachea is also more complex since it 
includes several cell types and tissues, i.e. chondrocytes, epithelial cells 
and neurons. Recently, assays were done with decellularized matrixes 
used with chondrocytes and bronchial epithelial cells. Synthetic scaffolds 
including nanocomposite polymers complexed with growth factors are 
also tried to optimize progenitor’s recruitment in the trachea. The loss of 
voluminous cartilage substances in head and neck area remains to date 
without effective treatment in terms of safety, preservation of cartilage 
properties and aesthetic performance.
Cells for cartilage tissue engineering
Like lot of tissue, cartilage undergoes extensive research aiming 
at its ex vivo reconstruction. They involve the choice of primary cells or 
progenitors combined with scaffolds, natural or synthetic, as they are 
decellularized, which are then incubated in appropriate conditions chosen 
to favor chondrogenesis. Primary chondrocytes would be suitable for this 
purpose but their small number in biopsies requires extensive amplifica-
tion. Unfortunately, chondrocytes undergo dedifferentiation during this 
step, which limits their use in cartilage engineering. In addition, the need 
of biopsies of cartilage from healthy area is likely to create donor sites. 
Instead, several progenitors are tested with a lot of advantages, such as 
the ease of obtaining, several types and tissue sources. The gold stan-
dard are mesenchymal stromal cells (MSCs) due to their proliferative rate 
and multipotency (Baugé and Boumédiene, 2015). Hundreds of studies, 
in vitro, in vivo or clinical trials, described their suitability to repair large 
cartilaginous and connective tissue defects. They derived mainly from bone 
marrow, but are also obtained from blood, umbilical cord, Wharton jelly, 
amniotic liquid, dental pulp, adipose tissue, synovial tissue and perichon-
drium (Mazor et al., 2014). Even their molecular signature is not completely 
defined, these cells are known to harbor several surface markers such as 
CD28, CD 33, CD44, CD 71, CD73, CD90, CD91, CD 105, CD106, CD 120a, 
CD 124, CD 131, CD 166 and class I HLA. In addition, MSCs are negative 
to others markers, mainly hematopoietic ones, i.e. CD14, CD31, CD34, 
CD45, CD 117. While many tissues contain MSCs, they are not equal for 
the construction of different types of cartilage. Indeed, specificities of 
some areas require the expression of peculiar ECM. For example, auricular 
cartilage which is elastin-rich is more likely obtained by using progeni-
tors from amniotic liquid or from auricular perichondrium (Kunisaki, et al. 
2007, Takebe, 2012). Therefore, the investigation of multiple sources of 
progenitors would bring more precise definition on the choice of which 
cells to use to target a specific cartilage.
Scaffolds
A lot of them are assayed for their biocompatibility. Requirements of 
scaffolds include also immunocompatibility, ability to mimics the host tis-
sue shape. They should also allow cell adhesion, proliferation and differen-
tiation in a tridimensional environment (Korkusuz et al., 2016). Regarding 
the great variety of tissues to be constructed, their characteristics depend 
on the location of the graft. Hence, porosity, ability to support strength and 
biodegradability, are needed for certain tissues. Among natural scaffolds 
used for cartilage are agarose, alginate, collagens and hyaluronic acid or 
chitosan (Agrawal and Pramanik, 2019). Beside, several combinations of 
synthetic biomaterials serve also to mimic the biomechanical properties 
of cartilage by hosting chondrocytes or differentiating progenitors. The 
fact that they should be biodegradable is yet a question open to debate. 
Polyhydroxyacids like PLLA, PCL, PGA and also polyurethan are then used, 
some of them tried for cartilage reconstruction (Pourbashir et al., 2019). 
Polyethylen glycol which is already FDA approved is also an option, where 
its analogs are investigated. Recently, new synthetic scaffolds gave good 
outcomes. For example, sericin, a silkworm protein that could be func-
tionalized with methacryloyl, and RAD16-I, a self-assembling peptide 
into nanofiber network yielded promising results in vitro. 
In vitro chondrogenesis environment
The achievement of chondrogenesis in vitro is a combination of multi-
ple conditions (Ciuffreda, et al., 2016). Addition of growth factors such as 
TGFbs, IGF, or Wnt as biochemical stimuli are widely used. Indeed, chon-
drogenic media are used for chondrogenesis induction and phenotype 
sustaining.  In addition, progenitor’s differentiation toward chondrocyte 
may need mechanical tension and sheer stress. CSM are mechanosen-
sitive and then chondrogenesis can be triggered by compression forces 
which modulate protein synthesis to achieve their differentiation (Gaut 
and Sugaya, 2015; Glatt et al., 2019). Cartilage is a hypoxic tissue with low 
oxygen content (1-7%). Therefore, hypoxia is usually used to ensure a pro-
per environment during cartilage engineering. At the molecular level, low 
oxygen tension activates peculiar transcription factors such as HIF-1 and 
HIF-2 (Duval et al., 2012), which in turn, modulate multiple target genes. 
Among them, specific cartilage markers like type II collagen and aggrecan 
are enhanced in hypoxia, while undesirable ones such as type I collagen 
are inhibited (Duval et al., 2016). Finally, in vitro chondrogenesis, should 
include culturing cells in bioreactors. These latter can ensure perfusion 
of cellularized matrixes, shaking with or without rolling and eventually 
compression for mechanical stimuli.
Cartilage bioprinting 
Since cartilage is an avascular and non-innervated tissue, it is obvious 
that it was one of the first tissues targeted by bioprinting. Indeed, except 
few progenitors embedded inside, this tissue contains a single cell type, 
namely chondrocytes. Therefore, it appears simple to try its construction 
once 3D printing came to tissue engineering. Several trials were done with Received 02 January  2019; Accepted 10 February  2019; Available online 15 February 2019
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different scaffolds or combination of them as bioinks (hydrogels, alginate, 
gelatin, chondroitin sulfate, lutrol...). They were printed as specific shapes 
corresponding to particular organs (ear, nose, trachea) before seeding 
them with cells (Bae et al., 2018; Di Gesu et al., 2019). Therefore, this 
approach might make bioprinting very beneficial for tissular reconstruc-
tion for several reasons. Indeed, it permits to replicate the anatomical 
forms while reducing surgical techniques and outcomes, to avoid donor 
site morbidity.  However, whatever the methods of biofabrication used, 
investigations are still ongoing to select the suitable scaffold material to 
ensure a good encapsulation and printing directly with living cells, knowing 
that they could be altered during printing and by biomechanical properties 
of bioinks. Moreover, a good bioink for cartilage should ensure adequate 
resistance to mechanical strength (Zamborsky et al., 2019). 
Conclusion
Despite its apparent simple structure with a single cell type, cartilage 
remains complex to be reconstructed in vitro. Multiple organs that contain 
this tissue exhibit differences at the biochemical level, explained by diver-
gent embryologic origins and then subsequent roles. These parameters 
should be taken into account during cartilage engineering by choosing 
appropriate progenitors that provide the right biochemistry of the desired 
tissue, and the appropriate scaffold that ensures a good environment for 
cell proliferation and chondrogenesis. The recent input of 3D printing 
technology brought encouraging outcomes and will probably help to 
improve this field by reducing surgical   operating times and replicating 
complex anatomical forms. 
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